S'abonner

Connection

// Powered by Mass Cytometry - Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes

// Powered by Mass Cytometry - Dynamic CD8+ T cell responses to  cancer immunotherapy in human regional lymph nodes are disrupted in  metastatic lymph nodes

Rahim et al. show that immune checkpoint blockade activates CD8 T cell differentiation and proliferation in the lymph node, not within the tumor microenvironment, and these cells can be detected in transit via blood profiling.

Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes - ScienceDirect

Nanoparticle-Based Immunotherapy for Cancer

Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumors

Dynamics and specificities of T cells in cancer immunotherapy

Put me in, coach! Peripheral T cells are ready to play

Physiology of chemokines in the cancer microenvironment

Cytotoxic CD8+ T cells in cancer and cancer immunotherapy

Cisplatin Nanoparticles Promote Intratumoral CD8+ T Cell Priming via Antigen Presentation and T Cell Receptor Crosstalk

CD8+ T cell differentiation and dysfunction in cancer

Hedgehog blockade remodels the gut microbiota and the intestinal effector CD8+ T cells in a mouse model of mammary carcinoma - Laboratory Investigation

Allogeneic chimeric antigen receptor-T cells with CRISPR-disrupted programmed death-1 checkpoint exhibit enhanced functional fitness - Cytotherapy